Lista de obras - Valentina Appierto - Dominio Público Uruguay

4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells

artículo científico publicado en 2010

4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines

artículo científico publicado en 2006

A lipemia-independent NanoDrop®-based score to identify hemolysis in plasma and serum samples

artículo científico publicado en 2014

AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells

artículo científico publicado en 2012

Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells

artículo científico publicado en 2002

Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.

artículo científico publicado en 2007

Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity

artículo científico publicado en 2009

Challenges in using circulating miRNAs as cancer biomarkers

artículo científico publicado en 2015

Circulating Biomarkers for Prediction of Treatment Response

artículo científico publicado en 2015

Cloning of a gene encoding a DNase I-like endonuclease in the human Xq28 region.

artículo científico publicado en 1996

Comment re: continuous rather than intermittent administration of fenretinide in leukoplakia

artículo científico publicado en 2009

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line

artículo científico publicado en 2001

Expression of the epidermal growth factor receptor gene in human intestinal metaplasia: a preliminary report

article

Feasibility of circulating miRNA microarray analysis from archival plasma samples

artículo científico

Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome

artículo científico publicado en 2003

Functional characterization of a human DNase-like protein encoded by a gene positioned in Xq28.

artículo científico publicado en 1997

Identification of a U7snRNA homologue mapping to the human Xq27.1 region, between the DXS1232 and DXS119 loci

artículo científico publicado en 1997

Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.

artículo científico publicado en 2004

Implications of stemness-related signaling pathways in breast cancer response to therapy

artículo científico publicado en 2014

Improved procedure for the preparation of DNA restriction fragments suitable for sequencing

artículo científico publicado en 1994

Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells

artículo científico publicado en 2004

Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas.

artículo científico publicado en 1997

MicroRNA detection in plasma samples: how to treat heparinized plasma

artículo científico publicado en 2013

PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation

artículo científico publicado en 2009

Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide

artículo científico publicado en 2007

Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation

artículo científico publicado en 2015

Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients

artículo científico publicado en 2010

Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells

artículo científico publicado en 1999

Sequence and gene content in 35 kb genomic clone mapping in the human Xq27.1 region.

artículo científico publicado en 1997

Water-soluble derivatives of 4-oxo-N-(4-hydroxyphenyl) retinamide: synthesis and biological activity

artículo científico publicado en 2016

Lista de obras de Valentina Appierto

4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells

4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines

A lipemia-independent NanoDrop®-based score to identify hemolysis in plasma and serum samples

AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells

Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells

Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.

Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity

Challenges in using circulating miRNAs as cancer biomarkers

Circulating Biomarkers for Prediction of Treatment Response

Cloning of a gene encoding a DNase I-like endonuclease in the human Xq28 region.

Comment re: continuous rather than intermittent administration of fenretinide in leukoplakia

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line

Expression of the epidermal growth factor receptor gene in human intestinal metaplasia: a preliminary report

Feasibility of circulating miRNA microarray analysis from archival plasma samples

Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome

Functional characterization of a human DNase-like protein encoded by a gene positioned in Xq28.

Identification of a U7snRNA homologue mapping to the human Xq27.1 region, between the DXS1232 and DXS119 loci

Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.

Implications of stemness-related signaling pathways in breast cancer response to therapy

Improved procedure for the preparation of DNA restriction fragments suitable for sequencing

Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells

Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas.

MicroRNA detection in plasma samples: how to treat heparinized plasma

PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation

Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide

Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation

Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients

Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells

Sequence and gene content in 35 kb genomic clone mapping in the human Xq27.1 region.

Water-soluble derivatives of 4-oxo-N-(4-hydroxyphenyl) retinamide: synthesis and biological activity